Cargando…

Persistence of Robust Humoral Immune Response in Coronavirus Disease 2019 Convalescent Individuals Over 12 Months After Infection

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection elicits varying degrees of protective immunity conferred by neutralizing antibodies (nAbs). In this study, we report the persistence of nAb responses over 12 months after infection despite their decreasing trend notic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyakawa, Kei, Kubo, Sousuke, Stanleyraj Jeremiah, Sundararaj, Go, Hirofumi, Yamaoka, Yutaro, Ohtake, Norihisa, Kato, Hideaki, Ikeda, Satoshi, Mihara, Takahiro, Matsuba, Ikuro, Sanno, Naoko, Miyakawa, Masaaki, Shinkai, Masaharu, Miyazaki, Tomoyuki, Ogura, Takashi, Ito, Shuichi, Kaneko, Takeshi, Yamamoto, Kouji, Goto, Atsushi, Ryo, Akihide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689844/ https://www.ncbi.nlm.nih.gov/pubmed/35071683 http://dx.doi.org/10.1093/ofid/ofab626

Ejemplares similares

Sustained Neutralizing Antibodies 6 Months Following Infection in 376 Japanese COVID-19 Survivors
por: Goto, Atsushi, et al.
Publicado: (2021)

Development of an Automated Chemiluminescence Assay System for Quantitative Measurement of Multiple Anti-SARS-CoV-2 Antibodies
por: Kubo, Sousuke, et al.
Publicado: (2021)

Detecting SARS-CoV-2 neutralizing immunity: highlighting the potential of split nanoluciferase technology
por: Jeremiah, Sundararaj Stanleyraj, et al.
Publicado: (2022)

Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles
por: Miyakawa, Kei, et al.
Publicado: (2020)

Phosphopeptide enrichment using Phos-tag technology reveals functional phosphorylation of the nucleocapsid protein of SARS-CoV-2
por: Ino, Yoko, et al.
Publicado: (2022)

Molecular and Epidemiological Characterization of Emerging Immune-Escape Variants of SARS-CoV-2
por: Miyakawa, Kei, et al.
Publicado: (2022)

Characterization and Utilization of Disulfide-Bonded SARS-CoV-2 Receptor Binding Domain of Spike Protein Synthesized by Wheat Germ Cell-Free Production System
por: Yamaoka, Yutaro, et al.
Publicado: (2022)

Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera
por: Miyakawa, Kei, et al.
Publicado: (2021)

All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity
por: Morita, Takeshi, et al.
Publicado: (2021)

Potent antiviral effect of silver nanoparticles on SARS-CoV-2
por: Jeremiah, Sundararaj S., et al.
Publicado: (2020)

Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 vaccination
por: Kato, Hideaki, et al.
Publicado: (2022)

Evasion of vaccine-induced humoral immunity by emerging sub-variants of SARS-CoV-2
por: Koyama, Takahiko, et al.
Publicado: (2022)

Cleavage of TANK-Binding Kinase 1 by HIV-1 Protease Triggers Viral Innate Immune Evasion
por: Jeremiah, Sundararaj Stanleyraj, et al.
Publicado: (2021)

Development of a Monoclonal Antibody Targeting HTLV-1 Envelope gp46 Glycoprotein and Its Application to Near-Infrared Photoimmuno-Antimicrobial Strategy
por: Hatayama, Yasuyoshi, et al.
Publicado: (2022)

Development of highly sensitive and rapid antigen detection assay for diagnosis of COVID-19 utilizing optical waveguide immunosensor
por: Funabashi, Rikako, et al.
Publicado: (2021)

Antibody titers against the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2 induced by BNT162b2 vaccination measured using automated chemiluminescent enzyme immunoassay
por: Kato, Hideaki, et al.
Publicado: (2022)

Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach
por: Kimura, Yayoi, et al.
Publicado: (2021)

Prediction models for neutralization activity against emerging SARS-CoV-2 variants: A cross-sectional study
por: Goto, Atsushi, et al.
Publicado: (2023)

Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests
por: Yamaoka, Yutaro, et al.
Publicado: (2021)

Development of Monoclonal Antibodies and Antigen-Capture ELISA for Human Parechovirus Type 3
por: Goto, Keiko, et al.
Publicado: (2020)

Prolyl Isomerase Pin1 Regulates the Stability of Hepatitis B Virus Core Protein
por: Nishi, Mayuko, et al.
Publicado: (2020)

Generation and Utilization of a Monoclonal Antibody against Hepatitis B Virus Core Protein for a Comprehensive Interactome Analysis
por: Nakai, Yusuke, et al.
Publicado: (2022)

Engineering Cellular Biosensors with Customizable Antiviral Responses Targeting Hepatitis B Virus
por: Matsunaga, Satoko, et al.
Publicado: (2020)

Primary Care-Based Investigation of the Effect of Sitagliptin on Blood Pressure in Hypertensive Patients With Type 2 Diabetes
por: Yuasa, Shouhei, et al.
Publicado: (2017)

Introduction to the special issue “SIR Model and Macroeconomics of COVID-19”
por: Iwamoto, Yasushi, et al.
Publicado: (2021)

Introduction to the special issue “The Impacts of COVID-19 on the Japanese Economy”
por: Iwamoto, Yasushi, et al.
Publicado: (2021)

BCA2/Rabring7 Promotes Tetherin-Dependent HIV-1 Restriction
por: Miyakawa, Kei, et al.
Publicado: (2009)

Development of a cell-based assay to identify hepatitis B virus entry inhibitors targeting the sodium taurocholate cotransporting polypeptide
por: Miyakawa, Kei, et al.
Publicado: (2018)

Development of Parallel Reaction Monitoring Mass Spectrometry Assay for the Detection of Human Norovirus Major Capsid Protein
por: Kimura, Yayoi, et al.
Publicado: (2022)

Factor Analysis of Changes in Hemoglobin A1c After 12 Months of Sitagliptin Therapy in Patients With Type 2 Diabetes
por: Yuasa, Shouhei, et al.
Publicado: (2016)

HUMORAL ANTIBODIES AND RESISTANCE OF VACCINATED AND CONVALESCENT MONKEYS TO POLIOMYELITIS VIRUS
por: Sabin, Albert B., et al.
Publicado: (1936)

Humoral and cellular response in convalescent COVID-19 lupus patients
por: Solé, Cristina, et al.
Publicado: (2022)

Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patients
por: Dewald, Felix, et al.
Publicado: (2023)

Factors Associated With Reduced Efficacy of Sitagliptin Therapy: Analysis of 93 Patients With Type 2 Diabetes Treated for 1.5 Years or Longer
por: Kanamori, Akira, et al.
Publicado: (2013)

Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency
por: Honjo, Kazuhito, et al.
Publicado: (2020)

Tofogliflozin decreases body fat mass and improves peripheral insulin resistance
por: Matsuba, Ren, et al.
Publicado: (2018)

Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals
por: Beaudoin-Bussières, Guillaume, et al.
Publicado: (2020)

Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab
por: Adamec, Ivan, et al.
Publicado: (2022)

Reduced Replication Efficacy of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in “Mini-gut” Organoids
por: Miyakawa, Kei, et al.
Publicado: (2022)

Assessment of Salivary Nitric Oxide Levels in Elite University Athletes in Japan: Findings From a Cross Sectional Study Design
por: Sone, Ryota, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hag7mr6nfuuatgo8h8mcil80la